首页|胶质瘤组织细胞糖酵解相关酶表达及代谢物变化及与免疫抑制蛋白水平相关性

胶质瘤组织细胞糖酵解相关酶表达及代谢物变化及与免疫抑制蛋白水平相关性

扫码查看
目的 探讨胶质瘤组织细胞糖酵解相关酶表达及代谢物变化及与免疫抑制蛋白水平相关性.方法 选取2022年1月到2023年12月河南省人民医院诊治的神经胶质瘤组织和癌旁组织作为研究对象,采用荧光定量聚合酶链反应(PCR)分析癌旁组织和胶质瘤组织糖酵解相关酶表达水平,并采用试剂盒测定丙酮酸、乳酸等代谢物的变化.免疫荧光分析癌旁组织和胶质瘤组织CD8阳性T淋巴细胞的浸润水平;采用免疫组织化学分析癌旁组织和胶质瘤组织程序性死亡分子配体-1蛋白表达水平;组间计量数据比较采用t检验.结果 神经胶质瘤组织中己糖激酶2(HK2)、磷酸甘油激酶1(PGK1)、乳酸脱氢酶A(LDHA)和丙酮酸激酶2(PKM2)mRNA表达水平(1.53±0.19、1.70±0.22、1.81±0.18、1.79±0.22)明显高于癌旁组织(0.81±0.16、1.01±0.17、0.88±0.14、0.98±0.18),差异有统计学意义(t=24.950、19.180、27.900、18.850,P<0.05).神经胶质瘤细胞组织中丙酮酸和乳酸水平[(56.24±14.27)、(8.31±1.96)mg/ml prot]明显高于癌旁组织(29.87±11.29)、(2.84±1.02)mg/ml prot],差异有统计学意义(t=9.721、16.570,P<0.05).神经胶质瘤细胞组织中CD8淋巴细胞比例[(2.48±0.59)%]明显低于癌旁组织[(5.06± 1.17)%],差异有统计学意义(t=13.160,P<0.05).神经胶质瘤组织中程序性死亡分子配体-1和程序性死亡受体-1表达水平(1.57±0.19、1.62±0.19)明显高于癌旁组织(0.72±0.12、0.87± 0.14),差异有统计学意义(t=16.3900、13.770,P<0.05).HK2、PGK1、LDHA 和 PKM2 mRNA 表达水平与程序性死亡分子配体-1蛋白表达水平呈正相关(r=0.145、0.105、0.217、0.209,P<0.05).结论 胶质瘤组织中糖酵解酶己糖激酶2、磷酸甘油激酶1、乳酸脱氢酶A和丙酮酸激酶水平显著增加,与程序性死亡分子配体-1表达水平呈正相关.
Expression of glycolysis-related enzymes and metabolites in glioma tissues and their correlation with immunosuppressive protein levels
Objective To investigate the expression of glycolysis-related enzymes and metabolites in glioma tissues and their correlation with immunosuppressive protein levels.Methods Glioma tissues and adjacent tissues obtained from our hospital from January 2022 to December 2023 were selected as the research objects.The expression levels of glycolysis-related enzymes in adjacent tissues and glioma tissues were analyzed by fluorescence quantitative polymerase chain reaction(PCR).The changes of pyruvate and lactic acid were measured by a kit.The infiltration levels of CD8 positive T lymphocytes in adjacent tissues and glioma tissues were analyzed by immunofluorescence.The expression levels of programmed death ligand-1 protein in adjacent tissues and glioma tissues were analyzed by immunohistochemistry.The t test was used for comparison of measurement data between groups.Results The mRNA expression levels of hexokinase 2(HK2),phosphoglycerate kinase 1(PGK1),lactate dehydrogenase A(LDHA)and pyruvate kinase 2(PKM2)in glioma tissues(1.53±0.19,1.70±0.22,1.81±0.18,1.79±0.22)were signifi-cantly higher than those in adjacent tissues(0.81±0.16,1.01±0.17,0.88±0.14,0.98±0.18,t=24.950,19.180,27.900,18.850,P<0.05).The levels of pyruvate and lactic acid in glioma tissues[(56.24±14.27),(8.31±1.96)mg/ml protein]were significantly higher than those in adjacent tissues[(29.87±11.29),(2.84±1.02)mg/ml protein,t=9.721,16.570,P<0.05].The proportion of CD8 lymphocytes in glioma tissues[(2.48±0.59)%]was significantly lower than that in adjacent tissues[(5.06±1.17)%,t=13.160,P<0.05].The expression levels of programmed death ligand-1 and pro-grammed death receptor-1 in glioma tissues(1.57±0.19,1.62±0.19)were significantly higher than those in adjacent tissues(0.72±0.12,0.87±0.14,t=16.3900,13.770,P<0.05).The mRNA ex-pression levels of hexokinase 2,phosphoglycerate kinase 1,lactate dehydrogenase A and pyruvate kinase 2 were positively correlated with the protein expression level of programmed death ligand-1(r=0.145,0.105,0.217,0.209,P<0.05).Conclusion The glycolytic enzymes hexokinase 2,phosphoglycerate kinase 1,lactate dehydrogenase A and pyruvate kinase are significantly increased in glioma tissues,and are positively correlated with the expression level of programmed death ligand-1.

GliomaGlycolysisImmunosuppression

王江涛、申汉威、张喆、陈玉升、郭杨、陈航

展开 >

河南省人民医院郑州大学人民医院河南大学人民医院神经外科,郑州 450003

神经胶质瘤 糖酵解 免疫抑制

河南省科技厅项目

222102310056

2024

中华实验外科杂志
中华医学会

中华实验外科杂志

CSTPCD
影响因子:0.759
ISSN:1001-9030
年,卷(期):2024.41(5)
  • 4